The TAPS Tool, developed by a study team in the NIDA Clinical Trials Network (CTN-0059), is a 2-step screening and brief assessment approach. TAPS-1, the screening component, asks about frequency of use of tobacco, alcohol (above guideline-recommended daily limits), illicit drugs, and nonmedical use of prescription medications within the previous 12 months. If the participants reports having used one of the substances, TAPS-2 then asks more specific follow-up questions regarding use in the past 3 months
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov. |
Tobacco, Alcohol, Prescription Medication, and Other Substance Use Screening
Abbreviation
TAPS
Catalog Link
Description
Category
Substance Use
Studies Using This Assessment